B
ABMD

Barings’s Abiomed Inc ABMD Stock Holding History

Barings’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-951
Closed -$236K – 330
2022
Q2 		$236K Buy
+951
New +$257K 0.01% 281
2018
Q2 		– Sell
-3,150
Closed -$917K – 953
2018
Q1 		$917K Hold
3,150
– – 0.01% 548
2017
Q4 		$590K Sell
3,150
-50
-2% -$9.34K 0.01% 658
2017
Q3 		$540K Hold
3,200
– – 0.01% 632
2017
Q2 		$459K Buy
+3,200
New +$430K 0.01% 643

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Barings's ABMD Position: Q3 2022 in Review

Barings sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 951 shares — an estimated $236K sold.

Barings first reported a position in ABMD in Q2 2017 and held it in 5 quarters. The position peaked at $917K in Q1 2018. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Barings reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Barings sold 951 Abiomed Inc shares in Q3 2022, an estimated $236K.
  • Barings first reported a position in Abiomed Inc in Q2 2017 and held it in 5 quarters.
  • Barings's Abiomed Inc position peaked at $917K in Q1 2018.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Barings's 13F filing for Q3 2022, filed 14 Nov 2022.